XML 90 R38.htm IDEA: XBRL DOCUMENT v3.2.0.727
Guarantor and Non-Guarantor Financial Statements (Tables)
6 Months Ended
Jun. 30, 2015
Guarantor and Non-Guarantor Financial Statement [Abstract]  
Schedule of Condensed Financial Statements
CONDENSED CONSOLIDATING BALANCE SHEET
(In millions of dollars)
June 30, 2015
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$

 
$
49.8

 
$
4.5

 
$

 
$
54.3

Short-term investments
 

 
30.0

 

 

 
30.0

Receivables:
 
 
 
 
 
 
 
 
 
 
Trade receivables — net
 

 
134.7

 
3.9

 

 
138.6

Intercompany receivables
 
29.2

 
78.7

 
1.8

 
(109.7
)
 

Other
 

 
2.6

 
3.3

 

 
5.9

Inventories
 

 
212.8

 
6.1

 
(1.6
)
 
217.3

Prepaid expenses and other current assets
 
0.2

 
99.8

 
0.4

 

 
100.4

Total current assets
 
29.4

 
608.4

 
20.0

 
(111.3
)
 
546.5

Investments in and advances to subsidiaries
 
1,026.8

 
33.6

 

 
(1,060.4
)
 

Property, plant and equipment — net
 

 
439.5

 
25.0

 

 
464.5

Long-term intercompany receivables
 

 

 
10.2

 
(10.2
)
 

Deferred tax assets — net
 

 
141.6

 

 
7.1

 
148.7

Intangible assets — net
 

 
31.3

 

 

 
31.3

Goodwill
 

 
37.2

 

 

 
37.2

Other assets
 
4.0

 
19.0

 
0.1

 

 
23.1

Total
 
$
1,060.2

 
$
1,310.6

 
$
55.3

 
$
(1,174.8
)
 
$
1,251.3

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
0.6

 
$
67.5

 
$
9.3

 
$

 
$
77.4

Intercompany payable
 
74.3

 
39.5

 
3.7

 
(117.5
)
 

Accrued salaries, wages and related expenses
 

 
31.5

 
2.9

 

 
34.4

Other accrued liabilities
 
1.5

 
50.1

 

 

 
51.6

Short-term capital lease
 

 
0.1

 

 

 
0.1

Total current liabilities
 
76.4

 
188.7

 
15.9

 
(117.5
)
 
163.5

Net liabilities of Salaried VEBA
 

 
16.4

 

 

 
16.4

Deferred tax liabilities
 

 

 
0.8

 

 
0.8

Long-term intercompany payable
 

 
10.2

 

 
(10.2
)
 

Long-term liabilities
 

 
80.9

 
5.9

 

 
86.8

Long-term debt
 
225.0

 

 

 

 
225.0

Total liabilities
 
301.4

 
296.2

 
22.6

 
(127.7
)
 
492.5

 
 
 
 
 
 
 
 
 
 
 
Total stockholders’ equity
 
758.8

 
1,014.4

 
32.7

 
(1,047.1
)
 
758.8

Total
 
$
1,060.2

 
$
1,310.6

 
$
55.3

 
$
(1,174.8
)
 
$
1,251.3


CONDENSED CONSOLIDATING BALANCE SHEET
(In millions of dollars)
December 31, 2014
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$

 
$
175.3

 
$
2.4

 
$

 
$
177.7

Short-term investments
 

 
114.0

 

 

 
114.0

Receivables:
 
 
 
 
 
 
 
 
 
 
Trade receivables — net
 

 
126.1

 
3.2

 

 
129.3

Intercompany receivables
 
204.2

 
4.0

 
0.9

 
(209.1
)
 

Other
 

 
5.6

 
5.3

 

 
10.9

Inventories
 

 
208.0

 
7.6

 
(0.9
)
 
214.7

Prepaid expenses and other current assets
 
85.1

 
93.1

 
0.4

 

 
178.6

Total current assets
 
289.3

 
726.1

 
19.8

 
(210.0
)
 
825.2

Investments in and advances to subsidiaries
 
1,209.2

 
32.5

 

 
(1,241.7
)
 

Property, plant and equipment — net
 

 
437.4

 
17.5

 

 
454.9

Long-term intercompany receivables
 

 

 
15.9

 
(15.9
)
 

Net assets of Union VEBA
 

 
340.1

 

 

 
340.1

Deferred tax assets — net
 

 
23.8

 

 
7.1

 
30.9

Intangible assets — net
 

 
32.1

 

 

 
32.1

Goodwill
 

 
37.2

 

 

 
37.2

Other assets
 
4.4

 
18.8

 
0.1

 

 
23.3

Total
 
$
1,502.9

 
$
1,648.0

 
$
53.3

 
$
(1,460.5
)
 
$
1,743.7

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
1.3

 
$
73.8

 
$
6.3

 
$

 
$
81.4

Intercompany payable
 

 
221.3

 
3.3

 
(224.6
)
 

Accrued salaries, wages and related expenses
 

 
36.5

 
3.1

 

 
39.6

Other accrued liabilities
 
88.2

 
43.8

 
0.8

 

 
132.8

Current portion of long-term debt
 
172.5

 

 

 

 
172.5

Short-term capital lease
 

 
0.1

 

 

 
0.1

Total current liabilities
 
262.0

 
375.5

 
13.5

 
(224.6
)
 
426.4

Net liabilities of Salaried VEBA
 

 
17.2

 

 

 
17.2

Deferred tax liabilities
 

 

 
0.9

 

 
0.9

Long-term intercompany payable
 

 
15.9

 

 
(15.9
)
 

Long-term liabilities
 

 
50.3

 
8.0

 

 
58.3

Long-term debt
 
225.0

 

 

 

 
225.0

Total liabilities
 
487.0

 
458.9

 
22.4

 
(240.5
)
 
727.8

 
 
 
 
 
 
 
 
 
 
 
Total stockholders’ equity
 
1,015.9

 
1,189.1

 
30.9

 
(1,220.0
)
 
1,015.9

Total
 
$
1,502.9

 
$
1,648.0

 
$
53.3

 
$
(1,460.5
)
 
$
1,743.7


CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
(In millions of dollars)
Quarter Ended June 30, 2015
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Net sales
 
$

 
$
358.3

 
$
33.5

 
$
(24.6
)
 
$
367.2

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of products sold:
 
 
 
 
 
 
 
 
 
 
Cost of products sold, excluding depreciation and amortization and other items
 

 
289.4

 
28.9

 
(23.5
)
 
294.8

Unrealized loss on derivative instruments
 

 
1.5

 

 

 
1.5

Depreciation and amortization
 

 
7.8

 
0.3

 

 
8.1

Selling, general, administrative, research and development:
 
 
 
 
 
 
 
 
 
 
Selling, general, administrative, research and development
 
1.4

 
19.5

 
3.2

 
(0.5
)
 
23.6

Net periodic postretirement benefit cost relating to Salaried VEBA
 

 
0.6

 

 

 
0.6

Loss on removal of Union VEBA net assets
 

 
1.6

 

 

 
1.6

Total selling, general, administrative, research and development
 
1.4

 
21.7

 
3.2

 
(0.5
)
 
25.8

Total costs and expenses
 
1.4

 
320.4

 
32.4

 
(24.0
)
 
330.2

Operating (loss) income
 
(1.4
)
 
37.9

 
1.1

 
(0.6
)
 
37.0

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest (expense)
 
(4.9
)
 
(0.3
)
 

 

 
(5.2
)
Other income, net
 

 
0.3

 
0.1

 

 
0.4

(Loss) income before income taxes
 
(6.3
)
 
37.9

 
1.2

 
(0.6
)
 
32.2

Income tax (provision) benefit
 

 
(15.8
)
 
1.4

 
2.4

 
(12.0
)
 Earnings in equity of subsidiaries
 
26.5

 
2.1

 

 
(28.6
)
 

Net income
 
$
20.2

 
$
24.2

 
$
2.6

 
$
(26.8
)
 
$
20.2

 
 
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
20.6

 
$
24.6

 
$
2.6

 
$
(27.2
)
 
$
20.6












CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE (LOSS) INCOME
(In millions of dollars)
Six Months Ended June 30, 2015
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Net sales
 
$

 
$
721.7

 
$
68.2

 
$
(51.0
)
 
$
738.9

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of products sold:
 
 
 
 
 
 
 
 
 
 
Cost of products sold, excluding depreciation and amortization and other items
 

 
585.8

 
60.5

 
(49.2
)
 
597.1

Unrealized gains on derivative instruments
 

 
6.0

 

 

 
6.0

Depreciation and amortization
 

 
15.5

 
0.6

 

 
16.1

Selling, general, administrative, research and development:
 
 
 
 
 
 
 
 
 
 
Selling, general, administrative, research and development
 
2.4

 
40.2

 
4.8

 
(1.1
)
 
46.3

Net periodic postretirement benefit cost relating to VEBAs
 

 
1.2

 

 

 
1.2

Loss on removal of Union VEBA net assets
 

 
493.8

 

 

 
493.8

Total selling, general, administrative, research and development
 
2.4

 
535.2

 
4.8

 
(1.1
)
 
541.3

Total costs and expenses
 
2.4

 
1,142.5

 
65.9

 
(50.3
)
 
1,160.5

Operating (loss) income
 
(2.4
)
 
(420.8
)
 
2.3

 
(0.7
)
 
(421.6
)
Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest (expense) income
 
(14.4
)
 
(0.8
)
 

 
0.2

 
(15.0
)
Other income (expense), net
 

 
0.8

 
0.2

 
(0.2
)
 
0.8

(Loss) income before income taxes
 
(16.8
)
 
(420.8
)
 
2.5

 
(0.7
)
 
(435.8
)
Income tax benefit
 

 
156.1

 
1.4

 
6.3

 
163.8

(Loss) earnings in equity of subsidiaries
 
(255.2
)
 
3.2

 

 
252.0

 

Net (loss) income
 
$
(272.0
)
 
$
(261.5
)
 
$
3.9

 
$
257.6

 
$
(272.0
)
 
 
 
 
 
 
 
 
 
 
 
Comprehensive (loss) income
 
$
(204.7
)
 
$
(194.3
)
 
$
4.0

 
$
190.3

 
$
(204.7
)






CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
(In millions of dollars)
Quarter Ended June 30, 2014
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Net sales
 
$

 
$
335.7

 
$
34.0

 
$
(25.6
)
 
$
344.1

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of products sold:
 
 
 
 
 
 
 
 
 
 
Cost of products sold, excluding depreciation and amortization and other items
 

 
270.8

 
29.7

 
(25.0
)
 
275.5

Unrealized gains on derivative instruments
 

 
(1.6
)
 

 

 
(1.6
)
Depreciation and amortization
 

 
7.5

 
0.2

 

 
7.7

Selling, general, administrative, research and development:
 
 
 
 
 
 
 
 
 
 
Selling, general, administrative, research and development
 
1.2

 
18.5

 
2.9

 
(0.6
)
 
22.0

Net periodic postretirement benefit income relating to VEBAs
 

 
(6.1
)
 

 

 
(6.1
)
Total selling, general, administrative, research and development
 
1.2

 
12.4

 
2.9

 
(0.6
)
 
15.9

Other operating charges, net
 

 
0.2

 

 

 
0.2

Total costs and expenses
 
1.2

 
289.3

 
32.8

 
(25.6
)
 
297.7

Operating (loss) income
 
(1.2
)
 
46.4

 
1.2

 

 
46.4

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest expense
 
(9.3
)
 

 

 
0.1

 
(9.2
)
Other income, net
 
0.4

 
0.8

 
0.7

 
(0.1
)
 
1.8

(Loss) income before income taxes
 
(10.1
)
 
47.2

 
1.9

 

 
39.0

Income tax (provision) benefit
 

 
(17.8
)
 
(0.5
)
 
3.8

 
(14.5
)
Earnings in equity of subsidiaries
 
34.6

 
1.4

 

 
(36.0
)
 

Net income
 
$
24.5

 
$
30.8

 
$
1.4

 
$
(32.2
)
 
$
24.5

 
 
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
26.6

 
$
33.0

 
$
1.3

 
$
(34.3
)
 
$
26.6








CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME
(In millions of dollars)
Six Months Ended June 30, 2014
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Net sales
 
$

 
$
662.8

 
$
67.1

 
$
(50.7
)
 
$
679.2

Costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of products sold:
 
 
 
 
 
 
 
 
 
 
Cost of products sold, excluding depreciation and amortization and other items
 

 
549.7

 
58.1

 
(49.4
)
 
558.4

Unrealized gains on derivative instruments
 

 
(3.6
)
 

 

 
(3.6
)
Depreciation and amortization
 

 
14.6

 
0.5

 

 
15.1

Selling, general, administrative, research and development:
 
 
 
 
 
 
 
 
 
 
Selling, general, administrative, research and development
 
2.2

 
35.1

 
6.2

 
(1.2
)
 
42.3

Net periodic postretirement benefit income relating to VEBAs
 

 
(11.7
)
 

 

 
(11.7
)
Total selling, general, administrative, research and development
 
2.2

 
23.4

 
6.2

 
(1.2
)
 
30.6

Other operating charges, net
 

 
0.2

 

 

 
0.2

Total costs and expenses
 
2.2

 
584.3

 
64.8

 
(50.6
)
 
600.7

Operating (loss) income
 
(2.2
)
 
78.5

 
2.3

 
(0.1
)
 
78.5

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest (expense) income
 
(18.6
)
 
0.4

 

 
0.2

 
(18.0
)
Other income, net
 
1.4

 
2.0

 
0.5

 
(0.2
)
 
3.7

(Loss) income before income taxes
 
(19.4
)
 
80.9

 
2.8

 
(0.1
)
 
64.2

Income tax (provision) benefit
 

 
(30.4
)
 
(0.8
)
 
7.3

 
(23.9
)
Earnings in equity of subsidiaries
 
59.7

 
1.8

 

 
(61.5
)
 

Net income
 
$
40.3

 
$
52.3

 
$
2.0

 
$
(54.3
)
 
$
40.3

 
 
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
43.3

 
$
55.2

 
$
2.1

 
$
(57.3
)
 
$
43.3








CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
(In millions of dollars)
Six Months Ended June 30, 2015
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
233.4

 
$
(190.1
)
 
$
5.0

 
$

 
$
48.3

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 

 
(14.3
)
 
(8.6
)
 

 
(22.9
)
Purchase of available for sale securities
 

 
(0.5
)
 

 

 
(0.5
)
Proceeds from disposition of available for sale securities
 

 
84.0

 

 

 
84.0

Net cash provided by (used in) investing activities
 

 
69.2

 
(8.6
)
 

 
60.6

Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
Repayment of Convertible Notes
 
(175.0
)
 

 

 

 
(175.0
)
Proceeds from cash-settled call options related to repayment of Convertible Notes
 
94.9

 

 

 

 
94.9

Payment for conversion premium related to repayment of Convertible Notes
 
(94.9
)
 

 

 

 
(94.9
)
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest
 

 
1.1

 

 

 
1.1

Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares
 
(3.0
)
 

 

 

 
(3.0
)
Repurchase of common stock
 
(41.4
)
 

 

 

 
(41.4
)
Cash dividend paid to stockholders
 
(14.0
)
 

 

 

 
(14.0
)
Intercompany loan
 

 
(5.7
)
 
5.7

 

 

Net cash (used in) provided by financing activities
 
(233.4
)
 
(4.6
)
 
5.7

 

 
(232.3
)
Net (decrease) increase in cash and cash equivalents during the period
 

 
(125.5
)
 
2.1

 

 
(123.4
)
Cash and cash equivalents at beginning of period
 

 
175.3

 
2.4

 

 
177.7

Cash and cash equivalents at end of period
 
$

 
$
49.8

 
$
4.5

 
$

 
$
54.3

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
(In millions of dollars)
Six Months Ended June 30, 2014
 
 
Parent
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
 
$
7.6

 
$
56.9

 
$
6.8

 
$

 
$
71.3

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 

 
(29.4
)
 
(0.7
)
 

 
(30.1
)
Purchase of available for sale securities
 

 
(23.4
)
 

 

 
(23.4
)
Proceeds from disposition of available for sale securities
 

 
25.0

 

 

 
25.0

Net cash used in investing activities
 

 
(27.8
)
 
(0.7
)
 

 
(28.5
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
Excess tax benefit upon vesting of non-vested shares and dividend payment on unvested shares expected to vest
 

 
0.8

 

 

 
0.8

Cancellation of shares to cover employees’ tax withholdings upon vesting of non-vested shares
 
(2.4
)
 

 

 

 
(2.4
)
Repurchase of common stock
 
(23.7
)
 

 

 

 
(23.7
)
Cash dividend paid to stockholders
 
(12.8
)
 

 

 

 
(12.8
)
Intercompany loan
 
31.3

 
(22.9
)
 
(8.4
)
 

 

Net cash used in financing activities
 
(7.6
)
 
(22.1
)
 
(8.4
)
 

 
(38.1
)
Net increase (decrease) in cash and cash equivalents during the period
 

 
7.0

 
(2.3
)
 

 
4.7

Cash and cash equivalents at beginning of period
 
5.0

 
157.7

 
6.8

 

 
169.5

Cash and cash equivalents at end of period
 
$
5.0

 
$
164.7

 
$
4.5

 
$

 
$
174.2